XML 39 R23.htm IDEA: XBRL DOCUMENT v3.22.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Schedule of Service Fee Revenue
Our total net revenues for the years ended December 31, 2021, 2020, and 2019 are presented in the table below (in thousands):
 
 202120202019
Commercial insurance$743,462 $584,035 $642,341 
Medicare280,911 217,928 237,427 
Medicaid34,731 25,619 28,283 
Workers' compensation/personal injury44,235 33,478 42,792 
Other patient revenue19,398 25,314 23,862 
Management fee revenue19,630 11,253 11,659 
Imaging on call and software10,525 10,798 17,317 
Other13,851 23,297 24,555 
Service fee revenue1,166,743 931,722 1,028,236 
Revenue under capitation arrangements148,334 140,118 125,943 
Total revenue$1,315,077 $1,071,840 $1,154,179 
Schedule of Effect of Derivative Instruments on Comprehensive (Loss) Income
A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):
Interest Rate Contracts
  
For the twelve months endedAmount of Gain (Loss) Recognized on Derivative, net of taxesLocation of Gain (Loss) Recognized
in Income on Derivative
December 31, 2021$—
December 31, 2020788Other Comprehensive Loss
December 31, 2019(4,383)Other Comprehensive Income
A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):
Interest Rate Contracts - Effective Portion
  
For the twelve months endedAmount of Loss Recognized on Derivative, net of taxesLocation of Loss Recognized
in Income on Derivative
December 31, 2021$—
December 31, 2020$(20,160)Other Comprehensive Loss
December 31, 2019$(5,870)Other Comprehensive Loss

A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):
Interest Rate Contracts - Ineffective Portion
For the twelve months endedAmount of gain (loss) recognized in income on derivative (current period ineffective portion)Location of gain (loss) recognized in Income on derivative (current period ineffective portion)Amount of loss reclassified from accumulated OCI into income (prior period effective portion)Location of loss reclassified from accumulated OCI into income (prior period effective portion)
December 31, 2021$21,670Other Income (Expense)$(3,695)Equity and Interest Expense
December 31, 2020$(2,528)Other Income (Expense)$(3,448)Equity and Interest Expense
Schedule of Fair Value of Assets and Liabilities
The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):
As of December 31, 2021
Level 1Level 2Level 3Total
Current and long term liabilities    
2019 SWAPS - Interest Rate Contracts$— $16,319 $— $16,319 
 
As of December 31, 2020
Level 1Level 2Level 3Total
Current and long term liabilities    
2019 SWAPS - Interest Rate Contracts$— $37,989 $— $37,989 
The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):
 
 As of December 31, 2021
 Level 1Level 2Level 3Total Fair ValueTotal Face Value
Term Loan Agreement and First Lien Term Loans$— $766,973 $— $766,973 $767,875 
 
 As of December 31, 2020
 Level 1Level 2Level 3Total Fair ValueTotal Face Value
Term Loan Agreement and First Lien Term Loans$— $661,640 $— $661,640 $662,403 
Schedule of Earnings Per Share Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):
 
 Years Ended December 31,
 202120202019
Net income (loss) attributable to RadNet, Inc. common stockholders$24,727 $(14,840)$14,756 
BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period52,496,679 50,891,791 49,674,858 
Basic net income (income) per share attributable to RadNet, Inc. common stockholders$0.47 $(0.29)$0.30 
DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS
Weighted average number of common shares outstanding during the period52,496,679 50,891,791 49,674,858 
Add nonvested restricted stock subject only to service vesting259,539 — 208,963 
Add additional shares issuable upon exercise of stock options and warrants664,815 — 360,185 
Weighted average number of common shares used in calculating diluted net income per share53,421,033 50,891,791 50,244,006 
Diluted net income (loss) per share attributable to RadNet, Inc. common stockholders$0.46 $(0.29)$0.29 
Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:
Nonvested restricted stock subject to service vesting— 329,159 — 
Shares issuable upon the exercise of stock options47,792 554,444 — 
Schedule of Investment in Joint Ventures
The following table is a summary of our investment in joint ventures during the years ended December 31, 2021 and December 31, 2020 (in thousands):
 
Balance as of December 31, 2019$34,470 
Equity contributions in existing and purchase of interest in joint ventures1,635 
Equity in earnings in these joint ventures7,945 
Distribution of earnings(9,522)
Balance as of December 31, 2020$34,528 
Equity contributions in existing and purchase of interest in joint ventures1,441 
Equity in earnings in these joint ventures10,967 
Distribution of earnings(4,707)
Balance as of December 31, 2021$42,229 
Schedule of Joint Venture Investment and Financial Information
The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2021 and 2020, respectively, and for the years ended December 31, 2021, 2020 and 2019, respectively, (in thousands):
December 31,
Balance Sheet Data:20212020
Current assets$37,186 $27,085 
Noncurrent assets73,592 68,686 
Current liabilities(12,919)(12,545)
Noncurrent liabilities(22,370)(21,582)
Total net assets$75,489 $61,644 
Book value of RadNet joint venture interests$34,930 $28,079 
Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill7,299 6,449 
Total value of RadNet joint venture interests$42,229 $34,528 
  
 202120202019
Net revenue$129,023 $101,921 $108,051 
Net income$21,893 $16,850 $18,624